Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults.
Clinical trial NCT02124161 · COMPLETED
Trial details
- NCT number
- NCT02124161
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2015-05-01
- Enrollment
- 882
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.